Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Mol Pharmacol. 2013 May;83(5):907-18. doi: 10.1124/mol.112.084632. Epub 2013 Feb 8.
The nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor is the fourth and most recently discovered member of the opioid receptor superfamily that also includes μ, δ, and κ opioid receptor subtypes (MOR, DOR, and KOR, respectively). The widespread anatomic distribution of the NOP receptor enables the modulation of several physiologic processes by its endogenous agonist, N/OFQ. Accordingly, the NOP receptor has gained a lot of attention as a potential target for the development of ligands with therapeutic use in several pathophysiological states. NOP receptor activation frequently results in effects opposing classic opioid receptor action; therefore, regulation of the NOP receptor and conditions affecting its modulatory tone are important to understand. Mounting evidence reveals a heterologous interaction of the NOP receptor with other G protein-coupled receptors, including MOR, DOR, and KOR, which may subsequently influence their function. Our focus in this review is to summarize and discuss the findings that delineate the cellular mechanisms of NOP receptor signaling and regulation and the regulation of other receptors by N/OFQ and the NOP receptor.
孤啡肽(N/OFQ)肽(NOP)受体是阿片受体超家族的第四个也是最新发现的成员,该超家族还包括 μ、δ 和 κ 阿片受体亚型(分别为 MOR、DOR 和 KOR)。NOP 受体的广泛解剖分布使其内源性激动剂 N/OFQ 能够调节多种生理过程。因此,NOP 受体作为治疗几种病理生理状态的配体的潜在靶点引起了广泛关注。NOP 受体的激活通常会导致与经典阿片受体作用相反的效果;因此,调节 NOP 受体及其调节音调的条件对于理解非常重要。越来越多的证据表明 NOP 受体与其他 G 蛋白偶联受体(包括 MOR、DOR 和 KOR)的异源相互作用,这可能随后影响它们的功能。我们在这篇综述中的重点是总结和讨论阐明 NOP 受体信号转导和调节以及 N/OFQ 和 NOP 受体对其他受体调节的细胞机制的发现。